Table 1.
Full sample, n = 113 | CDAI, n = 22 | PhGA, n = 25 | PtGA, n = 39 | RAPID3, n = 28 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Mean/f | SD/ % | f | SD/ % | f | SD/ % | f | SD/ % | f | SD/ % | |
Sex | ||||||||||
Female | 97 | 85.8% | 19 | 86.4% | 20 | 80.0% | 34 | 87.2% | 26 | 92.9% |
Mean age | 61.2 | 15.6 | 62.7 | 10.2 | 64.0 | 10.1 | 67.6 | 12.6 | 66.6 | 15.8 |
Mean disease durationa | 8.3 | 9.2 | 5.3 | 9.2 | 7.3 | 9.8 | 7 | 8.1 | 7.63 | 5.24 |
Mean BMI | 29.3 | 7.2 | 28.84 | 7.26 | 28.54 | 6.65 | 28.44 | 6.45 | 30.27 | 8.14 |
Ethnicity | ||||||||||
Asian | 1 | 0.9% | 1 | 4.5% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
Black | 7 | 6.2% | 1 | 4.5% | 2 | 8.0% | 3 | 7.7% | 3 | 10.7% |
Latino | 7 | 6.2% | 2 | 9.1% | 0 | 0.0% | 0 | 0.0% | 2 | 7.1% |
Other | 1 | 0.9% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
White | 75 | 66.4% | 18 | 81.8% | 22 | 88.0% | 23 | 59.0% | 9 | 32.1% |
Pacific Islander | 1 | 0.9% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
Not reported | 21 | 18.6% | 0 | 0.0% | 1 | 4.0% | 13 | 33.3% | 14 | 50.0% |
Insurance type | ||||||||||
Commercial | 50 | 44.2% | 10 | 45.5% | 11 | 44.0% | 9 | 23.1% | 7 | 25.0% |
Medicaid | 5 | 4.4% | 0 | 0.0% | 1 | 4.0% | 0 | 0.0% | 0 | 0.0% |
Medicare | 56 | 49.6% | 12 | 54.5% | 13 | 52.0% | 30 | 76.9% | 20 | 71.4% |
Other | 1 | 0.9% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 1 | 3.6% |
Unavailable | 1 | 0.9% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
BMI body mass index, CDAI Clinical Disease Activity Index, f frequency or frequency of observations, PhGA Physician Global Assessment, PtGA Patient Global Assessment, RAPID3 Routine Assessment of Patient Index Data, SD standard deviation
Patient and Physician Global Assessments
aDisease duration based on the following samples: Full sample n = 85; CDAI, n = 19; PhGA, n = 19; PtGA, n = 31; RAPID3, n = 19